Results 181 to 190 of about 485,556 (376)
Corrigendum to "Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis" [Heliyon Volume 10, Issue 12, June 30, 2024, Article e32875]. [PDF]
Razavinia A +8 more
europepmc +1 more source
Direct laser wrtitng of graphene with three different laser sources for fabrication of electromagnetic shields. ABSTRACT As electronic devices become an inseparable part of modern life, the challenge of electromagnetic interference (EMI) continues to grow.
Mahsa Barjinikhabbaz +5 more
wiley +1 more source
Evaluating Medical Text Summaries Using Automatic Evaluation Metrics and LLM-as-a-Judge Approach: A Pilot Study. [PDF]
Vasilev Y +8 more
europepmc +1 more source
Descriptive, comparative, and functional anatomy of the facial musculature in cattle (Bos taurus)
Abstract Facial expressions can provide insight into animal emotions and pain, but no standardized system for assessing the entire facial display in cattle (Bos taurus Linnaeus) exists. The Facial Action Coding System (FACS), originally developed for humans, identifies distinct facial movements based on mimetic muscles.
Maja Söderlind +6 more
wiley +1 more source
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar +35 more
wiley +1 more source
The future is now: Towards intelligent use of Generative AI in general practice. [PDF]
Burgers JS, Müller A.
europepmc +1 more source
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro +17 more
wiley +1 more source

